Ascalon International

Ascalon International is an oncology drug development company responsible for creating and managing an oncology drug portfolio. The company also conducts biomarker-based clinical trials in the field of oncology. Additionally, it focuses on developing clinical development and regulatory execution products through co-development with product owners or by acquiring products. The company has established a strategic and operational alliance with Parexel. Ascalon International, Inc., founded in 2009, is headquartered in Scottsdale, Arizona.